Announced Wed, 8 Jul · 15:01 IST
Routine RTA certificate filing for quarter ended June 2026
Compliance View source PDF
AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.9%1-day move
₹87.99
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-3.9-5.9-7.7-9.6-11.4-14.9————
Up moveDown movePending
AI summary
Aarey Drugs & Pharmaceuticals filed a Regulation 74(5) certificate from its Registrar MUFG Intime India confirming that shares received for dematerialisation during the quarter ending 30 June 2026 were properly processed, confirmed to depositories, and listed on stock exchanges. Old physical certificates were mutilated and cancelled as required. This is a standard quarterly compliance filing.
Likely market impact
Routine compliance filing with no material impact on shareholders or stock price.